condylox

Generic: podofilox

Labeler: allergan, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name condylox
Generic Name podofilox
Labeler allergan, inc.
Dosage Form GEL
Routes
TOPICAL
Active Ingredients

podofilox 5 mg/g

Manufacturer
Allergan, Inc.

Identifiers & Regulatory

Product NDC 0023-6118
Product ID 0023-6118_9f2892be-8330-4fd1-930e-b4d204df4e03
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA020529
Marketing Start 1997-03-13
Marketing End 2026-10-31

Pharmacologic Class

Physiologic Effect
decreased mitosis [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00236118
Hyphenated Format 0023-6118

Supplemental Identifiers

RxCUI
312466 351750
UPC
0300236118037
UNII
L36H50F353
NUI
N0000008732

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name condylox (source: ndc)
Generic Name podofilox (source: ndc)
Application Number NDA020529 (source: ndc)
Routes
TOPICAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/g
source: ndc
Packaging
  • 3.5 g in 1 TUBE, WITH APPLICATOR (0023-6118-03)
source: ndc

Packages (1)

0023-6118-03 3.5 g in 1 TUBE, WITH APPLICATOR (0023-6118-03)

Ingredients (1)

podofilox (5 mg/g)

Linked Drug Pages (1)

Condylox ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["TOPICAL"], "spl_id": "9f2892be-8330-4fd1-930e-b4d204df4e03", "openfda": {"nui": ["N0000008732"], "upc": ["0300236118037"], "unii": ["L36H50F353"], "rxcui": ["312466", "351750"], "spl_set_id": ["032e4bcb-b1ed-4029-b2a6-e92f3bf5cc37"], "pharm_class_pe": ["Decreased Mitosis [PE]"], "manufacturer_name": ["Allergan, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "3.5 g in 1 TUBE, WITH APPLICATOR (0023-6118-03)", "package_ndc": "0023-6118-03", "marketing_end_date": "20261031", "marketing_start_date": "19970313"}], "brand_name": "Condylox", "product_id": "0023-6118_9f2892be-8330-4fd1-930e-b4d204df4e03", "dosage_form": "GEL", "pharm_class": ["Decreased Mitosis [PE]"], "product_ndc": "0023-6118", "generic_name": "podofilox", "labeler_name": "Allergan, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Condylox", "active_ingredients": [{"name": "PODOFILOX", "strength": "5 mg/g"}], "application_number": "NDA020529", "marketing_category": "NDA", "marketing_end_date": "20261031", "marketing_start_date": "19970313"}